Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer
- Joseph A. Sparano
- , Michael R. Crager
- , Gong Tang
- , Robert J. Gray
- , Salomon M. Stemmer
- , Steven Shak
Research output: Contribution to journal › Article › peer-review
127
Link opens in a new tab
Scopus
citations